Combined Use of Transferrin and Hemoglobin in Detecting Gastrointestinal Bleeding
Gastrointestinal bleeding is a common clinical problem that requires accurate diagnosis and effective treatment. In order to improve the detection of gastrointestinal bleeding, a combination of transferrin and hemoglobin assays can be used.
Transferrin, an iron-binding protein in the blood, increases in cases of gastrointestinal bleeding due to the release of iron from the hemoglobin. This makes it a reliable marker for detecting bleeding. However, transferrin levels can also be affected by other factors, leading to false positive results.
Hemoglobin, the oxygen-carrying protein in red blood cells, decreases in cases of gastrointestinal bleeding due to the loss of red blood cells. Hemoglobin assays are highly sensitive and specific for detecting bleeding. However, they can also be influenced by other factors, leading to false negative results.
By combining the use of transferrin and hemoglobin assays, the accuracy of detecting gastrointestinal bleeding can be improved. Transferrin provides a reliable marker for bleeding, while hemoglobin assays offer high sensitivity. The combination of these two tests can help minimize false positive and false negative results, providing a more accurate diagnosis.
The diagnostic kit for fecal occult blood and the diagnostic kit for transferrin those independently developed and produced by Xiamen Wiz Biotech Co., Ltd., using the highly specific double antibody sandwich reaction principle and colloidal gold and immunochromatographic analysis technology. The test results can be obtained rapidly and in about only 10 to 15 minutes.
Xiamen Wiz Biotech Co., Ltd is a high-tech company engaging in researching and developing, producing and selling of rapid diagnostic reagents and the analyzing instruments. Focusing on technological innovation, WIZBIOTECH would like to take the advantage of existing channels to expand more medical markets, with a view to contribute more in the field of rapid diagnostic POCT.
